相关实验视频

Updated: May 25, 2025

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

在严重的COVID-19中比较巴里西提尼布和托西利祖马布的有效性和安全性:一项回顾性研究

Ioannis Tomos¹, Ioannis Grigoropoulos², Chrysavgi Kosti¹

¹5th Department of Respiratory Medicine, 'SOTIRIA' Chest Diseases Hospital of Athens, Athens, Greece.

Expert review of respiratory medicine

|February 28, 2025

概括

巴里西提尼布在严重的COVID-19患者中表现出比托西利祖马布更好的生存和安全结果. 建议进行进一步的临床试验,以确认免疫调节剂治疗的这些发现.

科学领域:

免疫学免疫学免疫学
病毒学病毒学
临床医学临床医学

背景情况:

严重的COVID-19治疗包括免疫调节剂,如托西利祖马布和巴里西提尼布.
关于它们在严重的COVID-19中有效性的比较研究有限.

研究的目的:

为了比较巴里西提尼布与托西利祖马布在住院的严重COVID-19患者的疗效和安全性.

主要方法:

连续非ICU重症COVID-19患者的回顾性分析,这些患者接受了巴里西提尼布或托西利祖马布治疗.
主要结局:死亡率/在第14天的输液,到氧断奶的时间,住院时间.
通过与治疗相关的不良事件评估安全性.

主要成果:

巴里西提尼布组在第14天死亡或输管风险显著降低 (OR:0.42).
经过调整后的分析证实了巴里西提尼布的保护作用 (OR:0.76).
托西利祖马布与较高的肝损伤率有关,而二次细菌感染没有差异.

结论:

与重症COVID-19的托西利祖马布相比,巴里西提尼布似乎提供了更好的生存和安全性.
需要进一步的随机临床试验来验证这些结果.

关键词:

严重的COVID-19 疾病巴里西提尼布 (baricitinib) 是一种药物.有效性有效性.在安全方面,安全是安全的.这就是为什么tocilizumab.

更多相关视频

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

相关概念视频

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...